FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3186049577> ?p ?o ?g. }

• W3186049577 abstract "Objective Autoantibodies are detected in most patients with rheumatoid arthritis (RA) and can be of the IgM, IgG or IgA subclass. Correlations between IgA autoantibodies and more severe disease activity have been previously reported, but the functional role of IgA autoantibodies in the pathogenesis of RA is ill understood. In this study, we explored the effect of IgA immune complexes on osteoclast mediated bone resorption. Methods Anti-citrullinated peptide antibody (ACPA) and anti-carbamylated protein (anti-CarP) antibody levels of the IgA and IgG isotype and rheumatoid factor (RF) IgA were determined in synovial fluid (SF) of RA patients. Monocytes, neutrophils, and osteoclasts were stimulated with precipitated immune complexes from SF of RA patients or IgA- and IgG-coated beads. Activation was determined by neutrophil extracellular trap (NET) release, cytokine secretion, and bone resorption. Results NET formation by neutrophils was enhanced by SF immune complexes compared to immune complexes from healthy or RA serum. Monocytes stimulated with isolated SF immune complexes released IL-6 and IL-8, which correlated with the levels of ACPA IgA levels in SF. Osteoclasts cultured in the presence of supernatant of IgA-activated monocytes resorbed significantly more bone compared to osteoclasts that were cultured in supernatant of IgG-activated monocytes (p=0.0233). Osteoclasts expressed the Fc receptor for IgA (FcαRI; CD89) and Fc gamma receptors. IgA-activated osteoclasts however produced significantly increased levels of IL-6 (p&lt;0.0001) and IL-8 (p=0.0007) compared to IgG-activated osteoclasts. Both IL-6 (p=0.03) and IL-8 (p=0.0054) significantly enhanced bone resorption by osteoclasts. Conclusion IgA autoantibodies induce release of IL-6 and IL-8 by immune cells as well as osteoclasts, which enhances bone resorption by osteoclasts. We anticipate that this will result in more severe disease activity in RA patients. Targeting IgA-FcαRI interactions therefore represents a promising novel therapeutic strategy for RA patients with IgA autoantibodies." @default.
• W3186049577 created "2021-08-02" @default.
• W3186049577 creator A5033300869 @default.
• W3186049577 creator A5045756314 @default.
• W3186049577 creator A5074353447 @default.
• W3186049577 creator A5075075803 @default.
• W3186049577 creator A5088515138 @default.
• W3186049577 creator A5090169437 @default.
• W3186049577 creator A5090198296 @default.
• W3186049577 date "2021-07-01" @default.
• W3186049577 modified "2023-10-01" @default.
• W3186049577 title "IgA Immune Complexes Induce Osteoclast-Mediated Bone Resorption" @default.
• W3186049577 cites W1913865297 @default.
• W3186049577 cites W1974718865 @default.
• W3186049577 cites W2001395916 @default.
• W3186049577 cites W2003284223 @default.
• W3186049577 cites W2006044067 @default.
• W3186049577 cites W2008737860 @default.
• W3186049577 cites W2009103286 @default.
• W3186049577 cites W2025335214 @default.
• W3186049577 cites W2032848182 @default.
• W3186049577 cites W2034976876 @default.
• W3186049577 cites W2035636765 @default.
• W3186049577 cites W2043606648 @default.
• W3186049577 cites W2044579908 @default.
• W3186049577 cites W2055159326 @default.
• W3186049577 cites W2056519358 @default.
• W3186049577 cites W2059353973 @default.
• W3186049577 cites W2063216829 @default.
• W3186049577 cites W2068319541 @default.
• W3186049577 cites W2069378615 @default.
• W3186049577 cites W2071619258 @default.
• W3186049577 cites W2094539147 @default.
• W3186049577 cites W2102722254 @default.
• W3186049577 cites W2115694552 @default.
• W3186049577 cites W2123585444 @default.
• W3186049577 cites W2123891089 @default.
• W3186049577 cites W2124197653 @default.
• W3186049577 cites W2125212735 @default.
• W3186049577 cites W2139339400 @default.
• W3186049577 cites W2139363027 @default.
• W3186049577 cites W2141522272 @default.
• W3186049577 cites W2148145578 @default.
• W3186049577 cites W2150663819 @default.
• W3186049577 cites W2150952126 @default.
• W3186049577 cites W2153522850 @default.
• W3186049577 cites W2153524721 @default.
• W3186049577 cites W2156444818 @default.
• W3186049577 cites W2160340969 @default.
• W3186049577 cites W2167131572 @default.
• W3186049577 cites W2167213128 @default.
• W3186049577 cites W2177851274 @default.
• W3186049577 cites W2197489357 @default.
• W3186049577 cites W2519199594 @default.
• W3186049577 cites W2553173693 @default.
• W3186049577 cites W2588276914 @default.
• W3186049577 cites W2589710212 @default.
• W3186049577 cites W2593097029 @default.
• W3186049577 cites W2594309628 @default.
• W3186049577 cites W2747969839 @default.
• W3186049577 cites W2786814765 @default.
• W3186049577 cites W2799950849 @default.
• W3186049577 cites W2802119898 @default.
• W3186049577 cites W2805311916 @default.
• W3186049577 cites W2901134829 @default.
• W3186049577 cites W2903773433 @default.
• W3186049577 cites W2936704347 @default.
• W3186049577 cites W2972460687 @default.
• W3186049577 cites W2998546112 @default.
• W3186049577 cites W3011534180 @default.
• W3186049577 cites W3014146563 @default.
• W3186049577 doi "https://doi.org/10.3389/fimmu.2021.651049" @default.
• W3186049577 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8281931" @default.
• W3186049577 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34276648" @default.
• W3186049577 hasPublicationYear "2021" @default.
• W3186049577 type Work @default.
• W3186049577 sameAs 3186049577 @default.
• W3186049577 citedByCount "7" @default.
• W3186049577 countsByYear W31860495772021 @default.
• W3186049577 countsByYear W31860495772022 @default.
• W3186049577 countsByYear W31860495772023 @default.
• W3186049577 crossrefType "journal-article" @default.
• W3186049577 hasAuthorship W3186049577A5033300869 @default.
• W3186049577 hasAuthorship W3186049577A5045756314 @default.
• W3186049577 hasAuthorship W3186049577A5074353447 @default.
• W3186049577 hasAuthorship W3186049577A5075075803 @default.
• W3186049577 hasAuthorship W3186049577A5088515138 @default.
• W3186049577 hasAuthorship W3186049577A5090169437 @default.
• W3186049577 hasAuthorship W3186049577A5090198296 @default.
• W3186049577 hasBestOaLocation W31860495771 @default.
• W3186049577 hasConcept C126322002 @default.
• W3186049577 hasConcept C134018914 @default.
• W3186049577 hasConcept C146562846 @default.
• W3186049577 hasConcept C159654299 @default.
• W3186049577 hasConcept C163764329 @default.
• W3186049577 hasConcept C170493617 @default.
• W3186049577 hasConcept C185592680 @default.
• W3186049577 hasConcept C203014093 @default.
• W3186049577 hasConcept C2776033226 @default.
• W3186049577 hasConcept C2776232647 @default.

• next